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Hirschfeld J, Howait M, Movila A, Parčina M, Bekeredjian-Ding I, Deschner J, Jepsen S,  
Kawai T. Assessment of the involvement of the macrophage migration inhibitory factor 
(MIF)-glucocorticoid regulatory dyad in MMP2 expression during periodontitis. Eur J Oral 
Sci. 
 
ABSTRACT 
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine and counter-
regulator of endogenous glucocorticoids. It is implicated in acute and chronic inflammatory 
diseases. This study investigated the role of the MIF-glucocorticoid (GC) regulatory dyad in 
MMP2 expression and release during periodontitis in vivo and in vitro. In a MIF knockout 
(KO) mouse model of ligature-induced periodontitis, gingival tissues and blood were 
collected and analyzed for levels of IL6, MIF, MMP2 and corticosterone. In addition, human 
gingival fibroblasts (HGF) were tested for production of IL6 and MMP2 after stimulation 
with hydrocortisone (HC), MIF, TNF-α or Fusobacterium nucleatum, a pathogen known to 
elicit immune responses during periodontitis. Wild type (WT) mice showed a local and 
systemic increase of MIF levels during inflammation, which was confirmed by increased 
local IL6 concentrations. Systemic GC were reduced in WT and MIF KO mice during 
inflammation with overall lower concentrations in MIF KO mice. In vivo and in vitro, MMP2 
production was not dependent on MIF or inflammatory stimuli, but was inhibited by HC. 
Therefore, MIF does not appear to stimulate MMP2 expression in the gingival tissues, 
whereas GC upregulate MIF and downregulate MMP2. Our findings further suggest that MIF 
may regulate systemic GC levels. 
 
Keywords: macrophage migration-inhibitory factors, glucocorticoids, periodontitis, 
inflammation, matrix metalloproteinase 2 
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Macrophage migration inhibitory factor (MIF), a proinflammatory mediator, plays a critical 
role in chronic and acute inflammatory diseases. Importantly, MIF is known to be the main 
counterregulator of endogenous anti-inflammatory glucocorticoids (GC), which are produced 
by the adrenal glands. For this reason, MIF has been classified as both a hormone and a 
cytokine (1). T cells were first reported to be potent producers of MIF (2). In further studies, 
the pituitary gland was also found to be a source of systemic MIF in response to 
inflammation, such as sepsis (3). Later, other leukocytes and fibroblasts were found to 
produce MIF (4), which elicited a variety of proinflammatory responses in inflamed tissues by 
upregulating other proinflammatory cytokines like IL6 (5). In addition to this, MIF is also 
implicated in the progression of several systemic inflammatory diseases, including 
rheumatoid arthritis (RA), atherosclerosis and diabetes mellitus, by lowering systemic cortisol 
levels (6-10). 
 
Periodontitis, triggered by pathogenic bacteria such as Fusobacterium nucleatum (F. 
nucleatum), is a chronic and destructive inflammatory disease of the tooth supporting tissues 
(11). In periodontitis, MIF was shown to promote osteoclastogenesis, thereby enhancing 
periodontal bone loss in an animal model (12). While MIF is known to be expressed in 
periodontital lesions, its impact on soft tissue degradation remains elusive. However, in other 
chronic inflammatory diseases like RA, MIF is known to upregulate matrix 
metalloproteinases (MMPs), which cause soft tissue breakdown (5). Several reports suggest 
that MMP2 promotes tissue destruction in periodontitis (13-16). More specifically, MMP2 
was found to participate in the degradation of extracellular matrixes, such as type I and IV 
collagen, laminin-332 and versican, which play a pivotal role in connecting the junctional 
epithelium to the tooth surface (17-20). 
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To better understand the role of MIF in regulating MMP2-mediated tissue degradation, a 
mouse model of ligature-induced periodontitis as well as in vitro approaches using stimulated 
gingival fibroblasts (HGFs) were employed. As MIF and endogenous GC constitute a 
functional dyad, the contribution of GC to MMP2 release was also investigated.  
 
 
MATERIALS AND METHODS 
Animals 
Six male C57BL/6J wild type (WT) mice and six male C57BL/6J MIF knockout (KO) mice 
were used in this study. WT animals were obtained from The Jackson Laboratories (Bar 
Harbor, ME, USA) (stock number 000664). Mif KO mice were produced as described 
previously (21) and generously provided by Dr. Abhay Satoskar (Ohio State University, 
Columbus, OH, USA) as homozygotes, backcrossed to a C57BL/6J background. The number 
of animals used was in accordance with, or exceeding, the number of animals employed in 
previously published studies using Mif KO mice in the context of periodontitis or MMP2 
research (12, 22). All mice were kept as previously described (23) and were six weeks old 
when the experiments were conducted. All procedures involving mouse experiments were 
approved by the Institutional Animal Care and Use Committee at The Forsyth Institute, 
Cambridge, MA, USA. 
 
Model of ligature-induced periodontitis 
For all animals, a 5-0 braided silk ligature (PERMA-HAND, Ethicon, Somerville, NJ, USA) 
was placed around the upper left secondary molar. Ligatures are thought to facilitate local 
accumulation of bacteria and thereby enhance bacteria-mediated inflammation and bone loss 
(24). Ligature placement was performed under general anesthesia. Ketamine-xylazine in 
sterile saline was injected once intraperitoneally at a dose of 100 mg/kg ketamine and 10 
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mg/kg xylazine. The ligature placement procedure took 5 to min per animal using a surgical 
microscope and metal clamps to keep the mouths open. While the right maxillary side was left 
untreated, ligatures where kept in place for 9 d. Eating and drinking behavior was monitored 
and did not change in the mice following ligature placement.  
 
Sample collection 
Blood was drawn at 7 pm on 0 d and 9 d in order to avoid the influence of circadian 
fluctuations of GC levels. Whole blood (0.5 ml) was collected from the retro-orbital area, 
allowed to clot for 20 min to obtain serum, and centrifuged at 2,000 x g for 10 min at 4°C. 
Supernatants were either assessed immediately or stored at -20°C until completion of the 
study. After 9 d of ligature placement, mice where euthanized with carbon dioxide gas by 
trained personnel. Subsequently, surrounding gingivae of the upper secondary molars of both 
sides were collected and immediately frozen in liquid nitrogen. Total ribonucleic acid (RNA) 
was extracted from gingival tissues using TRIzol reagent (Life Technologies, Carlsbad, CA, 
USA) for polymerase chain reaction (PCR) or tissue samples were stored at -80°C for one 
week.  
 
 
Cell culture 
Primary human gingival fibroblasts (HGFs) were harvested from five periodontally healthy 
donors as described in DAMANKI et al. (25), after obtaining written informed consent and 
approval of the Ethics Committee of the University of Bonn (#043/11). HGFs were cultured 
separately in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal 
calf serum (FCS) at 37°C in a 5% CO2 atmosphere. All cell culture assays were performed 
five times as biological replicates for each experimental condition. For experimental 
procedures, the medium was changed to 1% FCS and cells were seeded into separate 24-well 
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tissue culture plates at a density of 5x105 and allowed to adhere overnight. Next, MIF (20 
ng/ml), hydrocortisone (HC, 100 µg/ml) (Sigma Aldrich, Schnelldorf, Germany) or TNF-α 
(20 ng/ml) were added to the experimental wells. TNF-α is a potent and ubiquitous stimulator 
of inflammation and therefore served as a positive control (26). As a negative control, cells 
incubated with PBS were used. The concentrations used were based on those commonly 
described in the literature and verified by prior assays determining concentration dependent 
release of MIF and MMP2 (27-29). To mimick bacterial infection, HGFs were inoculated 
with F. nucleatum (ATCC 10953) at a MOI of 1:10. F. nucleatum is a pathogenic anaerobe 
microorganism that is found in human periodontal pockets. It is associated with periodontitis 
and elicits a strong immune response in host cells (11). Human T cells (Jurkat) were used as a 
positive control, as they are known to release high levels of MIF (2). Cells were incubated for 
12 h at 37°C in a 5% CO2 atmosphere. Subsequently, supernatants were collected and stored 
at -20°C until further use, whereas adherent cells were lysed, and total RNA was obtained 
using TRIzol reagent (Life Technologies, Darmstadt, Germany). All cell culture experiments 
were performed at the University Hospital Bonn. 
 
Polymerase chain reaction               
Total RNA from mouse gingival tissues and HGFs was converted into  complementary DNA 
(cDNA) (iScript cDNA synthesis kit, Bio-Rad, Hercules, CA, USA) using 1 µg of total RNA 
by addition of reverse transcriptase (0.5 µl) in a total of 20 µl solution. cDNA was analysed 
by quantitative PCR (qPCR) and reverse transcriptase PCR (RT-PCR), respectively. The 
custom primer sets used for murine tissues were company-designed and tested for Actb (β-
actin), Il6, Mif (Qiagen QuantiTect, Valencia, CA, USA) and Mmp2 (Real Time Primers, 
Elkins Park, PA, USA) mouse genes. qPCR was performed using a LightCycler 480 system 
with LightCycler 480 SYBR I Master mix (Roche Applied Science, Branford, CT, USA) for 
50 cycles. The PCR cycling profile consisted of an initial denaturation step at 95°C for 5 min, 
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followed by 50 cycles of 1) denaturation at 95°C for 15s and 2) annealing/extension 58-60°C 
for 60s. Melting curve analysis was also performed using a single cycle of 95°C for 20s, 60°C 
for 20s, 40°C for 1s and 95°C prior to the final cooling. The primers applied to HGF cDNA 
for reverse transcriptase PCR (RT-PCR) were designed using the NCBI Primer-BLAST tool 
and purchased from Thermo Fisher (Darmstadt, Germany). Primer sequences for the GADPH 
reference gene (NCBI accession number: NM_002046) were forward (5’  3’) 
TCCCTGAGCTGAACGGGAAG and reverse (5’  3’) GGAGGAGTGGGTGTCGCTGT 
(annealing temperature 64°C) for a product length of 218 bp. The sequences for human 
MMP2 (NCBI accession number: NM_001127891) were forward (5’  3’) 
ACTCCTGGCTCATGCCTTC and reverse (5’  3’) GCGTTCCCATACTTCACACG 
(annealing temperature 59°C) for a product length of 293 bp. Thirty-five cycles were run for 
each PCR, and after gel elctrophoresis, bands were visualized using ethidium bromide.  
                     
Enzyme-linked immunosorbent assay (ELISA)                       
Serum samples were assessed for corticosterone (murine cortisol) by competitive ELISA 
(Oxford Biomedical Research, Rochester Hills, MI, USA). MIF levels in serum samples and 
tissue lysates were measured by mouse MIF, DuoSet ELISA (R&D Systems, Minneapolis, 
MN, USA). HGF supernatants were analyzed by ELISA for MMP2 and IL6 (Boster Bio, 
Pleasanton, CA, USA) and MIF (Cloud-Clone, Houston, TX, USA) levels. All ELISA 
procedures were carried out according to the protocols provided by the manufacturers.  
Gelatin zymography                    
To assess whether MMP2 was secreted from HGFs as an active enzyme or as a proenzyme, 
gelatin zymography was conducted. Cell culture supernatatants were collected, and the total 
protein concentration was enhanced by filtering samples using Vivaspin 4 concentrators with 
a pore size of 10,000 MWCO (Sartorius Stedim Biotech, Gloucestershire, UK). Total protein 
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was measured by BCA assay (Life Technologies, Darmstadt, Germany). Sodium dodecyl 
sulfate gels containing 20 mg/ml gelatin (Merck Millipore, Darmstadt, Germany) were 
prepared, and polyacrylamide gel electrophoresis was performed under non-reducing 
conditions, adding 20 µg/ml of sample into each well. Subsequently, gels were stained with 
0.05% Coomassie Brilliant Blue G250 (Merck Millipore, Darmstadt, Germany) for 2h and 
destained in deionized water containing 8% acetic acid and 4% methanol for 2h. Destained 
bands were recorded using a Gel Doc XR+ system (Bio Rad, Hercules, CA, USA). 
Image processing                         
Images were acquired using Gene Tools image analysis software (Syngene, Frederick, MD, 
USA). Image J Fiji (National Insititutes of Health, Bethesda, MD, USA) was used for further 
image analysis and data quantification after performing PCR and gelatin zymography. 
Statistical analysis 
A post-hoc power analysis was conducted to determine the power (53%, P=0.05) of the 
MMP2-related outcomes in WT and KO animals for the observed effect size of d=1.3, using 
G*Power software (Version 1.3) (30). Relative gene expression was determined by applying 
the ∆∆CT calculation method, using β-actin as a control. Unpaired unequal variance t-tests 
were employed to calculate statistically significant differences between two groups. Paired 
unequal variance t-tests were applied for comparison of the means of two related groups on 
the same dependent variable. Quantification of PCR and zymography bands was statistically 
evaluated using One-way ANOVA and post hoc Tukey’s test. P values of ≤0.05 were 
considered statistically significant. All data are shown as mean values ± standard deviations 
(SD). 
 
 
RESULTS 
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Confirmation of MIF deficiency in MIF KO mice 
To confirm the MIF KO phenotype, DNA genotyping was performed. Moreover, gingival 
tissues were subjected to RT-PCR and analyzed for the presence of Mif mRNA, and serum 
was analyzed by ELISA for the presence of MIF protein. Genotyping, RT-PCR and ELISA 
showed no evidence of MIF in the KO animals (data not shown). 
 
MIF is not involved in the upregulation of local IL6 in periodontitis 
To confirm inflammation, murine gingival tissues and in vitro cell cultures were assessed for 
IL6 gene expression and quantities of IL6, respectively, as this cytokine is known to be 
significantly enhanced in periodontal lesions (31, 32). Nine days after ligature placement, 
local tissue mRNA levels of Il6 were markedly higher in inflamed tissues (0.006 ± 0.002 in 
WT animals and 0.005 ± 0.002 in KO animals) compared to those of the control non-ligatured 
sites in both animal groups (0.003 ± 0.001 in WT animals and 0.0005 ± 0.0002 in KO 
animals) (Fig. 1A,B), confirming the presence of inflammation. A more pronounced fold 
change was seen in Mif KO animals (10-fold) compared to WT mice (2-fold), indicating that 
IL6 was induced by other endogenous stimuli than MIF under inflammatory conditions. To 
further investigate the in vivo findings on the cellular level, an in vitro model of infected 
human gingival fibroblasts, the most abundant cell type in the gingival tissues, was employed. 
Increases in IL6 could also be observed in HGFs after stimulation with F. nucleatum (618.7 ± 
220.2 pg/ml), compared with the negative control (115.7 ± 45.1 pg/ml) (Fig. 1C).  
 
MIF levels increased, corticosterone levels decreased during inflammation 
Mif mRNA expression in WT mice was increased two-fold in inflamed sites compared to 
healthy sites (P=0.03). MIF protein levels in serum and gingival tissues were significantly 
higher during inflammation (Table 1). Notably, we observed an overall higher expression of 
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the Mif gene in relation to Actb compared to Il6, indicating that Mif may be produced in larger 
quantities in response to local inflammation. The level of MIF protein released from HGF 
cells was inducible by HC (9.5 ± 0.26 ng/ml vs. 4.9 ± 0.66 ng/ml in unstimulated HGFs), but 
not by TNF-α or F. nucleatum (Fig. 2), and was overall higher (nanogram range) than that of 
IL6 (picogram range), consolidating the observation that MIF may be produced in larger 
quantities than IL6. Corticosterone levels decreased during inflammation (136.1 ± 50.1 ng/ml 
on 9d vs. 186.5 ± 32.5 ng/ml on 0d in WT animals) and were overall lower in Mif KO animals 
(42.9 ± 27.7 ng/ml on day 9 vs. 91.7 ± 21.2 ng/m. on day 0) (Fig. 3), suggesting that 
corticosterone release may be MIF-dependent.  
 
MMP2 expression in gingival tissues is independent of MIF  
As shown in Fig. 4A, Mmp2 gene levels in both WT and Mif KO mice did not change 
significantly during periodontal inflammation (0.04 ± 0.03 in ligatured sites vs. 0.03 ± 0.02 in 
non-ligatured sites of WT mice and 0.04 ± 0.01 in ligatured sites vs. 0.05 ± 0.02 in non-
ligatured sites of Mif KO mice). Also in cell culture experiments, MMP2 release by HGFs 
was not influenced by exogenous MIF (Fig. 4B), however, it was significantly suppressed by 
HC (0 ± 0.29 ng/ml vs. 8.3 ± 0.58 ng/ml in unstimulated HGFs). MMP2 expression in HGFs 
in response to different stimuli was confirmed by RT-PCR (Fig. 5A,B), where the sample 
containing HC showed a lower intensity of the band, indicating its suppression of the MMP2 
gene (0.64 ± 0.03 AU vs. 1 ± 0.05 AU in unstimulated HGFs). Gelatin zymography confirmed 
that most MMP2 released was active (2-fold higher than pro-MMP2 in unstimulated controls) 
(Fig. 6A,B). Also, a more pronounced release of active MMP2 from cells stimulated with F. 
nucleatum could be observed compared to unstimulated HGFs (75.4 ± 5.7 AU vs. 61.6 ± 2.95 
AU), whereas less activation was seen in the sample containg HC (44.5 ± 1.66 AU), 
supporting the findings from MMP2 ELISA.  
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DISCUSSION 
 
MIF is a key proinflammatory mediator released during local and systemic inflammation (1). 
Our experiments were aimed at investigating whether MIF has an influence on the expression 
and release of MMP2 in gingival tissues during inflammation. A Mif KO mouse model as 
well as cell culture experiments were employed using stimulated HGFs, which are the most 
abundant structural cells in gingival tissues (33). This study revealed a higher expression of 
MIF in inflamed periodontal tissue and in HGFs when compared to IL6, as well as increased 
systemically circulating MIF levels. However, we could not verify a correlation between MIF 
and MMP2 in periodontal inflammation. PAKOZDI and colleagues demonstrated a significant 
increase of MMP2 expression in synovial fibroblasts in response to MIF during experimental 
RA in mice previously (22). RA and periodontitis are thought to be co-related chronic 
inflammatory diseases, both developing in a progressive manner if left untreated (34). 
Interestingly, MMP2 may have a protective function in RA, which was shown by two 
independent studies (35, 36), suggesting that MMP2 could counterbalance MIF to prevent 
excessive immune response in RA.  
 
Although the underlying mechanism for the protective role of MMP2 in RA has not been 
established, it is known that MMP2 can cleave the proinflammatory cytokine IL-1β and 
monocyte attractant protein 3 (37), thus exhibiting an anti-inflammatory effect. MMP2 in 
periodontitis, however, is known to be destructive to humans and rodents (15, 16). Although 
MIF was upregulated during periodontitis locally and systemically in our study, we found that 
it was not an influence factor for MMP2 expression in vivo and in vitro, suggesting that the 
effects of MIF on local MMP2 production are different in RA and periodontitis. Notably, 
HGFs released MMP2 without any external stimulus, but also upon stimulation, we observed 
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no change in the release of MMP2. This confirms the findings of other studies which reported 
that MMP2 is constitutively expressed by fibroblasts and other cell types, but is not 
upregulated during gingival inflammation (38, 39). A post-hoc power analysis was conducted 
in order to determine the power to detect differences between the MMP2 levels in the two 
animal groups and between healthy and inflamed tissues. Power was calculated with 53% for 
the observed effect size (d=1.3). Thus, we cannot completely rule out that a small or medium-
sized effect of MIF deficiency on MMP2 levels remained undetected in our study. In order to 
identify medium-sized MIF-dependent alterations (d=0.7) of MMP2 production in vivo at a 
power of 80%, larger animal cohorts (n=34 per group) need to be included in future studies. 
 
IL6, used as a local marker for inflammation in our study, showed a significantly higher fold 
change during inflammation in MIF KO mice compared to WT animals. It is possible that 
MIF deficiency leads to a compensatory upregulation of IL6 and other proinflammatory 
mediators during inflammation, as has been described previously (40, 41). Furthermore, 
HGFs were stimulated with F. nucleatum, a pathogenic anaerobe microorganism that is found 
in human periodontal pockets and elicits a strong immune response in host cells. We found 
that F. nucleatum could directly upregulate proinflammatory IL6 in HGFs, presumably via 
toll-like receptors 2 or 4 (38), both of which have been previously detected on the cell surface 
of HGFs (42). IL6 upregulation was observed in both animal model and cell culture 
experiments, indicating that oral bacteria accumulating in the area of ligature placement may 
contribute to IL6 release from murine HGFs via the TLR signalling cascade. 
 
MIF is a key modulator of endogenous glucocorticoids (GC). According to CALANDRA & 
BUCALA, MIF is the first mediator to be identified that can directly counter-regulate the 
immune inhibitory effects of glucocorticoids and thus plays a critical role in the host control 
of inflammation and immunity (43). More specifically, MIF counteracts the anti-
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inflammatory effects of GC on the cellular level, whereas GC can induce MIF release from 
the pituitary gland and from macrophages (44, 45). This process is concentration-dependent 
and is thought to control excessive or insufficient immune responses (46). In our experiments, 
a coherence between MIF and GC was detectable also: interestingly, in MIF KO animals 
significantly less systemic corticosterone was observed, and in both groups the levels 
decreased during inflammation. Although it is well known that stress, which may occur under 
experimental conditions, increases corticosterone levels in mice, it is also established that 
C57BL/6 animals are relatively stress-resistant (47, 48). Furthermore, all mice were handled 
and kept in an identical manner, yet these differences in systemic cortisol levels were highly 
significant. Moreover, the fact that corticosterone decreased over time indicates that stress 
was not a contributing factor. Taken together, these findings support that systemic cortisol 
induces MIF release, as described in numerous previous studies (1, 49), and that MIF may 
reversely be involved in glucocorticoid induction. An enhancement of corticosterone by MIF 
has, to our knowledge, not been reported in the literature, therefore this theory requires further 
investigation to confirm this putative function.  
 
In our experiments, we stimulated HGFs with hydrocortisol (HC), an exogenous 
glucocorticoid, in order to assess its effects on MMP2 release. The results from MMP2 
ELISA, RT-PCR and zymography showed a reduction of MMP2 on the protein and gene 
levels. These findings are supported by those of a previous study and corroborate the anti-
inflammatory role of glucocorticoids, suggesting that HC may help to decrease local tissue 
destruction mediated by MMP2 (50). Compared to other GC, HC has properties very similar 
to those of endogenous cortisone. For this reason, HC was chosen for our cell culture 
experiments. Other GC such as Dexamethasone also feature immunosuppressive properties 
and were reported to decrease MMP2 release from host cells (51, 52). Several GC were 
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shown to affect MIF production, however, data are discordant regarding their ability to up- or 
downregulate MIF (45, 53-56).   
 
It is important to note that ligature-induced periodontitis in mice does not perfectly correlate 
with the onset and long-term development of the disease in humans. However, our  in vivo 
mouse model combined with an in vitro model of stimulated HGFs may help to provide a 
better understanding of the involvement of MIF in periodontal inflammation. Importantly, this 
study investigated the expression of MMP2, not other MMPs or tissue inhibitors of matrix 
metalloproteinases (TIMPs). These could be addressed in future studies in order to gain 
further insight into the role of MIF in tissue degradation during periodontitis. MMP2 is 
secreted into the extracellular environment, however, pro-MMP2 can be released or remain 
bound to membrane-type 1 MMP and membrane-type tissue inhibitor of metalloproteinases 2 
(TIMP-2) (35, 57). Therefore, our zymography assays were confined to the measurement of 
released pro-MMP2 only. For a more accurate determination of the ratio between MMP2 and 
pro-MMP2, cell culture supernatants as well as cell membrane preparations should be used in 
future detection assays. 
 
As a further limitation of this study, HGFs were infected with F. nucleatum only, whereas 
periodontal inflammation is caused by an array of microbial species living in a biofilm 
community. However, F. nucleatum is a dominant microorganism within human oral biofilms 
and found at increased levels in periodontal disease (11). Moreover, F. nucleatum was 
reported to induce more significant changes in cultured cells than other microbial inducers of 
periodontitis (58, 59) and is known to play a pivotal role in biofilm formation (60). Mice were 
not infected with F. nucleatum, therefore, the underlying pathobiological mechanisms of 
periodontitis induction may have been different. As F. nucleatum is naturally found in the 
murine oral cavity (61) and experimental periodontitis is thought to be induced by the local 
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accumulation of bacteria around the ligature (24), F. nucleatum may have been present in the 
periodontitis lesions of our mouse model.    
 
Supernatants of F. nucleatum-stimulated HGFs showed an enhanced gelatinolytic activity in 
the zymography assays. The increased gelatin digestion by supernatants obtained from HGFs 
stimulated with F. nucleatum corresponded to the increased levels of released MMP2 in this 
study, and the proteolytic band coincided with the known MMP2 protein size. Although the 
potential of F. nucleatum proteases to degrade gelatin has been demonstrated (62), our own 
experiments using F. nucleatum only for gelatin zymography did not show detectable 
gelatinase activity. However, this may have been due to the low concentrations of bacteria 
(5x106 per well) used in this assay. Notably, F. nucleatum was reported to convert pro-MMP-
9 into the proteolytically active form (63), thus, it is possible that F. nucleatum may have 
similar effects on pro-MMP2. Little is known about proteases expressed by F. nucleatum and 
their ability to degrade host tissues, therefore, future studies may be aimed at investigating 
these as a potential pathomechanism in periodontal tissue breakdown.     
 
In conclusion, the results of this study indicate that MIF may be involved in the upregulation 
of systemic GC in mice, as knockout animals had overall lower levels of corticosterone. 
Furthermore, we demonstrated an inhibition of MMP2 production by GC. However, our 
findings do not support a modification of local MMP2 concentrations by MIF. Moreover, 
MMP2 production appears to be differentially regulated by MIF in RA and periodontitis. 
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FIGURE LEGENDS 
 
Fig. 1. Levels of proinflammatory IL6 in vivo and in vitro. A and B: Local tissue Il6 mRNA 
levels in healthy and inflamed gingivae nine days after ligature placement are shown as 
relative expressions in relation to β-actin and as fold change (compared to healthy sites). 
*P=0.05, **P=0.006 for healthy vs. inflamed tissues in WT and MIF KO mice and **P=0.01 
for inflamed sites in WT vs. MIF KO animals. Grey bars: WT mice (n=6), white bars: MIF 
KO mice (n=6). Results are shown as mean values ±SD, each sample was run in duplicate. C: 
Levels of IL6 released from HGFs after stimulation with HC, MIF or F. nucleatum (*P≤0.05 
compared to negative control). As a positive control, TNF-α, which is known to induce IL6 
release (64) was employed. Results are shown as mean values ±SD and represent five 
different donors; each sample was run in triplicate. 
 
Fig. 2. MIF protein release from HGFs. MIF release was inducible by hydrocortisol (HC), but 
not by TNF-α or F. nucleatum (*P≤0.05 compared to negative controls). Jurkat T cells, which 
are known to release high levels of MIF (65), were used as a positive control. Results are 
shown as mean values ±SD and represent five different donors; each sample was run in 
triplicate. 
 
Fig. 3. Local and systemic corticosterone levels during ligature-induced periodontitis. 
Corticosterone levels at baseline and after induction of inflammation in MIF KO and WT 
animals. Asterisks represent intergroup (WT vs. MIF KO animals) or intragroup (0d vs. 9d) 
differences in corticosterone levels (P*=0.05 **P≤0.004, ***P=0.0003). Blood was 
withdrawn from all animals at 7pm on both days from the retro-orbital area; each sample was 
run in triplicate ELISA wells.  
 
Page 27 of 37
European Journal of Oral Sciences
European Journal of Oral Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Manuscript Copy
 28
Fig. 4. MMP2 levels in murine gingival tissues and HGF supernatants. A: Mmp2 mRNA 
levels in WT and MIF KO mice in healthy and inflamed gingival sites shown as relative 
expressions in relation to β-actin and as fold change (compared to healthy sites). B: MMP2 
release by HGFs from five different donors in cell culture experiments in response to 
hydrocortisol (HC), MIF and F. nucleatum (***P=0.0003 compared to negative controls), 
each sample was run in triplicate wells.  
 
Fig.5. MMP2 gene expression in HGFs. Confirmation of MMP2 gene expression (RT-PCR) 
by HGFs in response to the stimuli shown and in comparison to GAPDH reference gene 
expression (A). Bands were quantified using ImageJ software (***P=0.0004 compared to the 
negative control) (B), gene expression was assessed in three independent experiments.  
 
Fig. 6. MMP2 activity. MMP2 activity was assessed by gelatin zymography, white bands 
indicate gelatinolytic activity (A). Quantification was performed using ImageJ software (B). 
Asterisks represent differences between pro-MMP2 and active MMP2 or differences between 
stimulated active MMP2 release and the negative control (**P≤0.005 and ***P≤0.0009). 
Gelatinolytic activity was assessed in three independent experiments. All bar graphs show 
results as mean values ±SD. 
 
Fig. 7. Summary of the putative roles of MIF, GC and MMP2 in periodontal inflammation. It 
is well established that MIF enhances inflammation (A), while glucocorticoids (GC) dampen 
the immune response (B). However, GC may evoke MIF release (C) (1 and 45), which then 
counteracts these antiinflammatory effects of GC (D). The findings of the present study 
support a proinflammatory role of MIF in periodontal inflammation. However, a direct 
relationship between MIF and MMP2, which is thought to have a destructive role in 
periodontitis (E), could not be detected (F). Instead, MIF seemed to increase systemic GC 
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levels in mice (G) and HC, an exogenous GC, was able to diminish MMP2 release (H). We 
hypothesize that systemic MIF and GC can promote the release of one another, but that MIF 
may not play a relevant role in MMP2 induction in periodontal inflammation. 
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Table 1 
Local and systemic presence of macrophage migration inhibitory factor (MIF) in vivo and in 
vitro 
 Healthy  SD Inflammed SD P value 
Relative Mif gene expression (ratio 
to ß-actin) 
1.47 0.81 3.03 0.73 0.03 
Mif gene expression as fold changes 
(ratio to ß-actin) compared to 
healthy sites 
1.00 0.55 2.10 0.49 0.03 
MIF tissue levels (ng/mg) 0.47 0.24 1.99 1.00 0.02 
MIF serum levels (ng/mL) 8.8 (day 0) 3.17 12.70 (day 9) 2.78 0.04 
Tissues of five wildtype animals per condition were used, and ELISA was run in duplicate 
wells. Systemic elevations of MIF in serum were observed after 9 d of ligature placement. All 
data are presented as means and standard deviations (SD). 
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Figure 1. Levels of proinflammatory IL-6 in vivo and in vitro. A and B: Local tissue IL-6 mRNA levels 
in healthy and inflamed gingivae nine days after ligature placement are shown as relative expressions in 
relation to β-actin and as fold change (compared to healthy sites). *p=0.05, **p=0.006 for healthy vs. 
inflamed tissues in WT and MIF KO mice and **p=0.01 for inflamed sites in WT vs. MIF KO animals. Grey 
bars: WT mice (n=6), white bars: MIF KO mice (n=6). Results are shown as mean values ±SD, each sample 
was run in duplicate. C: Levels of IL-6 released from HGFs after stimulation with HC, MIF or F. nucleatum 
(*p≤0.05 compared to negative control). As a positive control, TNF-α, which is known to induce IL-6 release 
(64) was employed. Results are shown as mean values ±SD and represent five different donors; each 
sample was run in triplicate.  
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Figure 2. MIF protein release from HGFs. MIF release was inducible by hydrocortisol (HC), but not by 
TNF-α or F. nucleatum (*p≤0.05 compared to negative controls). Jurkat T cells, which are known to release 
high levels of MIF (65), were used as a positive control. Results are shown as mean values ±SD and 
represent five different donors; each sample was run in triplicate.  
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Figure 3. Local and systemic corticosterone levels during ligature-induced periodontitis. 
Corticosterone levels at baseline and after induction of inflammation in MIF KO and WT animals. Asterisks 
represent intergroup (WT vs. MIF KO animals) or intragroup (day 0 vs. day 9) differences in corticosterone 
levels (p*=0.05 **p≤0.004, ***p=0.0003). Blood was withdrawn from all animals at 7pm on both days 
from the retro-orbital area; each sample was run in triplicate ELISA wells.  
 
 
95x90mm (300 x 300 DPI)  
 
 
Page 33 of 37
European Journal of Oral Sciences
European Journal of Oral Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Manuscript Copy
  
 
 
Figure 4. MMP-2 levels in murine gingival tissues and HGF supernatants. A: MMP-2 mRNA levels in 
WT and MIF KO mice in healthy and inflamed gingival sites shown as relative expressions in relation to β-
actin and as fold change (compared to healthy sites). B: MMP-2 release by HGFs from five different donors 
in cell culture experiments in response to hydrocortisol (HC), MIF and F. nucleatum (***p=0.0003 
compared to negative controls), each sample was run in triplicate wells.  
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Figure 5. MMP-2 gene expression in HGFs. Confirmation of MMP-2 gene expression (RT-PCR) by HGFs in 
response to the stimuli shown and in comparison to GAPDH reference gene expression (A). Bands were 
quantified using ImageJ software (***p=0.0004 compared to the negative control) (B), gene expression 
was assessed in three independent experiments.  
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Figure 6. MMP-2 activity. MMP-2 activity was assessed by gelatin zymography, white bands indicate 
gelatinolytic activity (A). Quantification was performed using ImageJ software (B). Asterisks represent 
differences between pro-MMP-2 and active MMP-2 or differences between stimulated active MMP-2 release 
and the negative control (**p≤0.005 and ***p≤0.0009). Gelatinolytic activity was assessed in three 
independent experiments. All bar graphs show results as mean values ±SD.  
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Figure 7. Summary of the putative roles of MIF, GC and MMP-2 in periodontal inflammation. It is 
well established that MIF enhances inflammation (A), while glucocorticoids (GC) dampen the immune 
response (B). However, GC may evoke MIF release (C) (1, 45), which then counteracts these 
antiinflammatory effects of GC (D). The findings of the present study support a proinflammatory role of MIF 
in periodontal inflammation. However, a direct relationship between MIF and MMP-2, which is thought to 
have a destructive role in periodontitis (E), could not be detected (F). Instead, MIF seemed to increase 
systemic GC levels in mice (G) and HC, an exogenous GC, was able to diminish MMP-2 release (H). We 
hypothesize that systemic MIF and GC can promote the release of one another, but that MIF may not play a 
relevant role in MMP-2 induction in periodontal inflammation.  
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